ride the antimicrobial activity of macrolides involves a point mutation in the 23S rDNA gene, which causes macrolides to have low affinity for ribosomes (1) . From 2011 to 2012, pneumonia caused by Mycoplasma was highly prevalent in Japan. Although macrolide-resistant M. pneumoniae first appeared in Japan around the year 2000 (1, 2) , the contribution of macrolide resistance to the recent epidemic was not determined.
From April 2011 to December 2013, we collected 117 throat swab specimens from pediatric patients diagnosed with lower respiratory inflammation, including pneumonia and acute bronchitis with suspected infection by M. pneumoniae, at 12 pediatrics departments of general hospitals or children's hospitals in Tokyo. The age range of patients who provided swab specimens was 0-15 years, and the mean age was 5.8 years. The samples were inoculated onto selective media including PPLO agar and broth (Becton Dickinson, Franklin Lakes, NJ, USA), and M. pneumoniae was isolated from 14 specimens. All study participants and/or guar- The domain V region of the 23S rDNA gene was sequenced using methods described previously (1) to investigate the prevalence of the point mutation conferring macrolide resistance. According to a previous report (3), extracted DNA was analyzed using multiplex PCR for classification based on the diversity of the RepMP4 and RepMP2/3 regions of the p1 gene. In addition, approximately 400 bp between the 2 Rep regions were amplified using a primer set (5′ -GCT GGC GCT AAG TTC GTT GGT A-3′and 5′ -CAA AGT CAG CAC TTA ATG GTT GGT CAG-3′ ) and were sequenced using another primer set (5′ -CTC GTT TTA GCG GGT ACC ATT ACC-3′ and 5′ -AGC TTA TTG GAC CAG TTG TAT ACC TGT C-3′ ) to estimate the number of AGT repeats in the variable number of tandem repeats (VNTR) region (4). Multiple-locus variablenumber tandem repeat analysis (MLVA) was performed as described previously (5), with a slight modification. Briefly, each locus was PCR amplified using Ex Taq DNA polymerase (Takara, Shiga, Japan) with 0.1 mM of each primer (Life Technologies Japan, Tokyo, Japan) in the standard solution according to the manufacturer's protocol for Ex Taq polymerase. In cases where PCR for Mix 1 (Mpn1, Mpn13, and Mpn14) was unsuccessful using 2 mM MgCl 2 , the concentration of MgCl 2 increased up to 3 mM. PCR amplicons were appropriately diluted and separated using electrophoresis (Applied Biosystems 3500 genetic analyzer; Life Technologies Japan).
The results of PCR analyses are shown in Table 1 . Almost all isolates (12 of 14 strains) had a point mutation in the domain V region of 23S rDNA, which is known to induce macrolide resistance (1), of which 11 isolates had an A2063G mutation, and one had an A2063T mutation. In p1 gene typing, all 14 isolates were classified as type I, whereas the repeat number of AGT triplets between the 2 Rep regions varied among isolates, ranging from 6 to 12; most isolates (5 isolates) had 8 repeats, suggesting that the AGT-VNTR region was more variable than the p1 genotype. The MLVA types of the 14 isolates appeared to be variable based on the nomenclature described by D áegrange et al. (5) . However, with the exception of the Mpn1 locus, there was apparent consistency among all 14 isolates with respect to the number of tandem repeats at the loci of Mpn13, Mpn14, Mpn15, and Mpn16, with 4, 5, 7, and 2 repeats, respectively.
A few previous studies have used MLVA to assess M. pneumoniae isolates over a similar investigation period (2011-2013) in Japan. Although Matsuda et al. (6) reported a study of MLVA to M. pneumoniae isolates in Japan in 2013, specific types were not described in their paper. Several investigations conducted in Beijing, China (7-9) over a similar period yielded similar results to those reported herein. These reports also showed isolates with the same 3 main molecular characteristics: macrolide resistance, p1 gene type I, and the 4-5-7-2 pattern in MLVA other than Mpn1. In contrast, similar investigations conducted in Israel (10), England (11) , and Australia (12) reported different results. Although the results of an investigation in France described the spread of type I strains, most of these strains were susceptible to macrolides (13) .
Our results provide valuable information for understanding the characteristics of M. pneumoniae in Japan, which may reflect the recent epidemic and help determine the optimal treatment method for patients with Mycoplasma infections.
